share_log

Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update

SEC ·  Aug 1 17:12
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more